How MedFluid is Targeting Antimicrobial Resistance with its Personalized Infection Screening Tool
XTalks
JANUARY 22, 2021
It identifies bacteria using both genotypic and phenotypic assessments within 1.5 MedFluid’s in vitro diagnostic (IVD) platform fAST is based on microfluidics as its core technology. The tool can select different combinations of multiple antibiotics deemed suitable for treating specific bacterial infections.
Let's personalize your content